BerGenBio ASA (BerGenBio ASA) Beginning Cash Position : $16.05 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is BerGenBio ASA Beginning Cash Position?

BerGenBio ASA's Beginning Cash Position for the quarter that ended in Dec. 2023 was $16.05 Mil.

BerGenBio ASA's quarterly Beginning Cash Position increased from Jun. 2023 ($6.76 Mil) to Sep. 2023 ($21.07 Mil) but then declined from Sep. 2023 ($21.07 Mil) to Dec. 2023 ($16.05 Mil).

BerGenBio ASA's annual Beginning Cash Position declined from Dec. 2021 ($80.35 Mil) to Dec. 2022 ($44.19 Mil) and declined from Dec. 2022 ($44.19 Mil) to Dec. 2023 ($14.29 Mil).

BerGenBio ASA Beginning Cash Position Historical Data

The historical data trend for BerGenBio ASA's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BerGenBio ASA Beginning Cash Position Chart

BerGenBio ASA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

39.94

29.13

80.35

44.19

14.29

BerGenBio ASA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial															22.78	14.32	6.76	21.07	16.05

BerGenBio ASA Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

BerGenBio ASA Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of BerGenBio ASA's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

BerGenBio ASA (BerGenBio ASA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (OTCPK:BRRGF) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

BGBIO:Norway 7BG:Germany

Address

Mollendalsbakken 9, Bergen, NOR, 5009

Website

https://www.bergenbio.com

BerGenBio ASA is a clinical stage oncology biotech company, which is engaged in developing therapeutics against novel drug targets that drive aggressive cancers. Its drug candidate bemcentinib (BGB324) is d is curently being developed in STK11 mutated NSCLC and severe respiratory infections including COVID-19. .